Medical Care
Global Irritable Bowel Syndrome (IBS) Diagnostics Market Research Report 2024
- Apr 15, 24
- ID: 168857
- Pages: 86
- Figures: 164
- Views: 17
Irritable bowel syndrome (IBS) is defined as a gastro-intestinal disorder causing discomfort in the stomach, along with diarrhea, and constipation. IBS can develop after a severe session of diarrhea (gastroenteritis) caused by bacteria or a virus. IBS might also be associated with a surplus of bacteria in the bowels (bacterial overgrowth). People exposed to stressful events, especially in childhood, tend to have more symptoms of IBS. IBS diagnostics is done through medical history, physical exam, and imaging tests. However, IBS is majorly diagnosed by lactose intolerance tests, breath test for bacterial overgrowth, blood test, and stool test. The tests are done based on symptoms such as constipation-predominant, diarrhea-predominant, or mixed. It can also detect by various imaging tests such as CT Scan or X-ray, upper endoscopy, and colonoscopy.
The global Irritable Bowel Syndrome (IBS) Diagnostics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Irritable Bowel Syndrome (IBS) Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Irritable Bowel Syndrome (IBS) Diagnostics.
Report Scope
The Irritable Bowel Syndrome (IBS) Diagnostics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Irritable Bowel Syndrome (IBS) Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Irritable Bowel Syndrome (IBS) Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Commonwealth Diagnostics International
Genova Diagnostics
Gemelli Biotech
Prometheus Laboratories
Inova Diagnostics, Inc.
Biohit Oyj
Aerodiagnostics, LLC.
Metabolic Solutions, Inc.
Sysmex Corporation
Buhlmann Laboratories AG
Segment by Type
Laboratory Tests
Imaging Tests
Segment by Application
Hospitals and Clinics
Diagnostic Centers
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Irritable Bowel Syndrome (IBS) Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Irritable Bowel Syndrome (IBS) Diagnostics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Irritable Bowel Syndrome (IBS) Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Irritable Bowel Syndrome (IBS) Diagnostics.
Report Scope
The Irritable Bowel Syndrome (IBS) Diagnostics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Irritable Bowel Syndrome (IBS) Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Irritable Bowel Syndrome (IBS) Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Commonwealth Diagnostics International
Genova Diagnostics
Gemelli Biotech
Prometheus Laboratories
Inova Diagnostics, Inc.
Biohit Oyj
Aerodiagnostics, LLC.
Metabolic Solutions, Inc.
Sysmex Corporation
Buhlmann Laboratories AG
Segment by Type
Laboratory Tests
Imaging Tests
Segment by Application
Hospitals and Clinics
Diagnostic Centers
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Irritable Bowel Syndrome (IBS) Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Irritable Bowel Syndrome (IBS) Diagnostics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Laboratory Tests
1.2.3 Imaging Tests
1.3 Market by Application
1.3.1 Global Irritable Bowel Syndrome (IBS) Diagnostics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals and Clinics
1.3.3 Diagnostic Centers
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Irritable Bowel Syndrome (IBS) Diagnostics Market Perspective (2019-2030)
2.2 Irritable Bowel Syndrome (IBS) Diagnostics Growth Trends by Region
2.2.1 Global Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Irritable Bowel Syndrome (IBS) Diagnostics Historic Market Size by Region (2019-2024)
2.2.3 Irritable Bowel Syndrome (IBS) Diagnostics Forecasted Market Size by Region (2025-2030)
2.3 Irritable Bowel Syndrome (IBS) Diagnostics Market Dynamics
2.3.1 Irritable Bowel Syndrome (IBS) Diagnostics Industry Trends
2.3.2 Irritable Bowel Syndrome (IBS) Diagnostics Market Drivers
2.3.3 Irritable Bowel Syndrome (IBS) Diagnostics Market Challenges
2.3.4 Irritable Bowel Syndrome (IBS) Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Irritable Bowel Syndrome (IBS) Diagnostics Players by Revenue
3.1.1 Global Top Irritable Bowel Syndrome (IBS) Diagnostics Players by Revenue (2019-2024)
3.1.2 Global Irritable Bowel Syndrome (IBS) Diagnostics Revenue Market Share by Players (2019-2024)
3.2 Global Irritable Bowel Syndrome (IBS) Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Irritable Bowel Syndrome (IBS) Diagnostics Revenue
3.4 Global Irritable Bowel Syndrome (IBS) Diagnostics Market Concentration Ratio
3.4.1 Global Irritable Bowel Syndrome (IBS) Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Irritable Bowel Syndrome (IBS) Diagnostics Revenue in 2023
3.5 Irritable Bowel Syndrome (IBS) Diagnostics Key Players Head office and Area Served
3.6 Key Players Irritable Bowel Syndrome (IBS) Diagnostics Product Solution and Service
3.7 Date of Enter into Irritable Bowel Syndrome (IBS) Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Irritable Bowel Syndrome (IBS) Diagnostics Breakdown Data by Type
4.1 Global Irritable Bowel Syndrome (IBS) Diagnostics Historic Market Size by Type (2019-2024)
4.2 Global Irritable Bowel Syndrome (IBS) Diagnostics Forecasted Market Size by Type (2025-2030)
5 Irritable Bowel Syndrome (IBS) Diagnostics Breakdown Data by Application
5.1 Global Irritable Bowel Syndrome (IBS) Diagnostics Historic Market Size by Application (2019-2024)
5.2 Global Irritable Bowel Syndrome (IBS) Diagnostics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Irritable Bowel Syndrome (IBS) Diagnostics Market Size (2019-2030)
6.2 North America Irritable Bowel Syndrome (IBS) Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Country (2019-2024)
6.4 North America Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Irritable Bowel Syndrome (IBS) Diagnostics Market Size (2019-2030)
7.2 Europe Irritable Bowel Syndrome (IBS) Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Country (2019-2024)
7.4 Europe Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Irritable Bowel Syndrome (IBS) Diagnostics Market Size (2019-2030)
8.2 Asia-Pacific Irritable Bowel Syndrome (IBS) Diagnostics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Region (2019-2024)
8.4 Asia-Pacific Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Irritable Bowel Syndrome (IBS) Diagnostics Market Size (2019-2030)
9.2 Latin America Irritable Bowel Syndrome (IBS) Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Country (2019-2024)
9.4 Latin America Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Irritable Bowel Syndrome (IBS) Diagnostics Market Size (2019-2030)
10.2 Middle East & Africa Irritable Bowel Syndrome (IBS) Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Country (2019-2024)
10.4 Middle East & Africa Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Commonwealth Diagnostics International
11.1.1 Commonwealth Diagnostics International Company Detail
11.1.2 Commonwealth Diagnostics International Business Overview
11.1.3 Commonwealth Diagnostics International Irritable Bowel Syndrome (IBS) Diagnostics Introduction
11.1.4 Commonwealth Diagnostics International Revenue in Irritable Bowel Syndrome (IBS) Diagnostics Business (2019-2024)
11.1.5 Commonwealth Diagnostics International Recent Development
11.2 Genova Diagnostics
11.2.1 Genova Diagnostics Company Detail
11.2.2 Genova Diagnostics Business Overview
11.2.3 Genova Diagnostics Irritable Bowel Syndrome (IBS) Diagnostics Introduction
11.2.4 Genova Diagnostics Revenue in Irritable Bowel Syndrome (IBS) Diagnostics Business (2019-2024)
11.2.5 Genova Diagnostics Recent Development
11.3 Gemelli Biotech
11.3.1 Gemelli Biotech Company Detail
11.3.2 Gemelli Biotech Business Overview
11.3.3 Gemelli Biotech Irritable Bowel Syndrome (IBS) Diagnostics Introduction
11.3.4 Gemelli Biotech Revenue in Irritable Bowel Syndrome (IBS) Diagnostics Business (2019-2024)
11.3.5 Gemelli Biotech Recent Development
11.4 Prometheus Laboratories
11.4.1 Prometheus Laboratories Company Detail
11.4.2 Prometheus Laboratories Business Overview
11.4.3 Prometheus Laboratories Irritable Bowel Syndrome (IBS) Diagnostics Introduction
11.4.4 Prometheus Laboratories Revenue in Irritable Bowel Syndrome (IBS) Diagnostics Business (2019-2024)
11.4.5 Prometheus Laboratories Recent Development
11.5 Inova Diagnostics, Inc.
11.5.1 Inova Diagnostics, Inc. Company Detail
11.5.2 Inova Diagnostics, Inc. Business Overview
11.5.3 Inova Diagnostics, Inc. Irritable Bowel Syndrome (IBS) Diagnostics Introduction
11.5.4 Inova Diagnostics, Inc. Revenue in Irritable Bowel Syndrome (IBS) Diagnostics Business (2019-2024)
11.5.5 Inova Diagnostics, Inc. Recent Development
11.6 Biohit Oyj
11.6.1 Biohit Oyj Company Detail
11.6.2 Biohit Oyj Business Overview
11.6.3 Biohit Oyj Irritable Bowel Syndrome (IBS) Diagnostics Introduction
11.6.4 Biohit Oyj Revenue in Irritable Bowel Syndrome (IBS) Diagnostics Business (2019-2024)
11.6.5 Biohit Oyj Recent Development
11.7 Aerodiagnostics, LLC.
11.7.1 Aerodiagnostics, LLC. Company Detail
11.7.2 Aerodiagnostics, LLC. Business Overview
11.7.3 Aerodiagnostics, LLC. Irritable Bowel Syndrome (IBS) Diagnostics Introduction
11.7.4 Aerodiagnostics, LLC. Revenue in Irritable Bowel Syndrome (IBS) Diagnostics Business (2019-2024)
11.7.5 Aerodiagnostics, LLC. Recent Development
11.8 Metabolic Solutions, Inc.
11.8.1 Metabolic Solutions, Inc. Company Detail
11.8.2 Metabolic Solutions, Inc. Business Overview
11.8.3 Metabolic Solutions, Inc. Irritable Bowel Syndrome (IBS) Diagnostics Introduction
11.8.4 Metabolic Solutions, Inc. Revenue in Irritable Bowel Syndrome (IBS) Diagnostics Business (2019-2024)
11.8.5 Metabolic Solutions, Inc. Recent Development
11.9 Sysmex Corporation
11.9.1 Sysmex Corporation Company Detail
11.9.2 Sysmex Corporation Business Overview
11.9.3 Sysmex Corporation Irritable Bowel Syndrome (IBS) Diagnostics Introduction
11.9.4 Sysmex Corporation Revenue in Irritable Bowel Syndrome (IBS) Diagnostics Business (2019-2024)
11.9.5 Sysmex Corporation Recent Development
11.10 Buhlmann Laboratories AG
11.10.1 Buhlmann Laboratories AG Company Detail
11.10.2 Buhlmann Laboratories AG Business Overview
11.10.3 Buhlmann Laboratories AG Irritable Bowel Syndrome (IBS) Diagnostics Introduction
11.10.4 Buhlmann Laboratories AG Revenue in Irritable Bowel Syndrome (IBS) Diagnostics Business (2019-2024)
11.10.5 Buhlmann Laboratories AG Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Irritable Bowel Syndrome (IBS) Diagnostics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Laboratory Tests
1.2.3 Imaging Tests
1.3 Market by Application
1.3.1 Global Irritable Bowel Syndrome (IBS) Diagnostics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals and Clinics
1.3.3 Diagnostic Centers
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Irritable Bowel Syndrome (IBS) Diagnostics Market Perspective (2019-2030)
2.2 Irritable Bowel Syndrome (IBS) Diagnostics Growth Trends by Region
2.2.1 Global Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Irritable Bowel Syndrome (IBS) Diagnostics Historic Market Size by Region (2019-2024)
2.2.3 Irritable Bowel Syndrome (IBS) Diagnostics Forecasted Market Size by Region (2025-2030)
2.3 Irritable Bowel Syndrome (IBS) Diagnostics Market Dynamics
2.3.1 Irritable Bowel Syndrome (IBS) Diagnostics Industry Trends
2.3.2 Irritable Bowel Syndrome (IBS) Diagnostics Market Drivers
2.3.3 Irritable Bowel Syndrome (IBS) Diagnostics Market Challenges
2.3.4 Irritable Bowel Syndrome (IBS) Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Irritable Bowel Syndrome (IBS) Diagnostics Players by Revenue
3.1.1 Global Top Irritable Bowel Syndrome (IBS) Diagnostics Players by Revenue (2019-2024)
3.1.2 Global Irritable Bowel Syndrome (IBS) Diagnostics Revenue Market Share by Players (2019-2024)
3.2 Global Irritable Bowel Syndrome (IBS) Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Irritable Bowel Syndrome (IBS) Diagnostics Revenue
3.4 Global Irritable Bowel Syndrome (IBS) Diagnostics Market Concentration Ratio
3.4.1 Global Irritable Bowel Syndrome (IBS) Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Irritable Bowel Syndrome (IBS) Diagnostics Revenue in 2023
3.5 Irritable Bowel Syndrome (IBS) Diagnostics Key Players Head office and Area Served
3.6 Key Players Irritable Bowel Syndrome (IBS) Diagnostics Product Solution and Service
3.7 Date of Enter into Irritable Bowel Syndrome (IBS) Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Irritable Bowel Syndrome (IBS) Diagnostics Breakdown Data by Type
4.1 Global Irritable Bowel Syndrome (IBS) Diagnostics Historic Market Size by Type (2019-2024)
4.2 Global Irritable Bowel Syndrome (IBS) Diagnostics Forecasted Market Size by Type (2025-2030)
5 Irritable Bowel Syndrome (IBS) Diagnostics Breakdown Data by Application
5.1 Global Irritable Bowel Syndrome (IBS) Diagnostics Historic Market Size by Application (2019-2024)
5.2 Global Irritable Bowel Syndrome (IBS) Diagnostics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Irritable Bowel Syndrome (IBS) Diagnostics Market Size (2019-2030)
6.2 North America Irritable Bowel Syndrome (IBS) Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Country (2019-2024)
6.4 North America Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Irritable Bowel Syndrome (IBS) Diagnostics Market Size (2019-2030)
7.2 Europe Irritable Bowel Syndrome (IBS) Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Country (2019-2024)
7.4 Europe Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Irritable Bowel Syndrome (IBS) Diagnostics Market Size (2019-2030)
8.2 Asia-Pacific Irritable Bowel Syndrome (IBS) Diagnostics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Region (2019-2024)
8.4 Asia-Pacific Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Irritable Bowel Syndrome (IBS) Diagnostics Market Size (2019-2030)
9.2 Latin America Irritable Bowel Syndrome (IBS) Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Country (2019-2024)
9.4 Latin America Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Irritable Bowel Syndrome (IBS) Diagnostics Market Size (2019-2030)
10.2 Middle East & Africa Irritable Bowel Syndrome (IBS) Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Country (2019-2024)
10.4 Middle East & Africa Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Commonwealth Diagnostics International
11.1.1 Commonwealth Diagnostics International Company Detail
11.1.2 Commonwealth Diagnostics International Business Overview
11.1.3 Commonwealth Diagnostics International Irritable Bowel Syndrome (IBS) Diagnostics Introduction
11.1.4 Commonwealth Diagnostics International Revenue in Irritable Bowel Syndrome (IBS) Diagnostics Business (2019-2024)
11.1.5 Commonwealth Diagnostics International Recent Development
11.2 Genova Diagnostics
11.2.1 Genova Diagnostics Company Detail
11.2.2 Genova Diagnostics Business Overview
11.2.3 Genova Diagnostics Irritable Bowel Syndrome (IBS) Diagnostics Introduction
11.2.4 Genova Diagnostics Revenue in Irritable Bowel Syndrome (IBS) Diagnostics Business (2019-2024)
11.2.5 Genova Diagnostics Recent Development
11.3 Gemelli Biotech
11.3.1 Gemelli Biotech Company Detail
11.3.2 Gemelli Biotech Business Overview
11.3.3 Gemelli Biotech Irritable Bowel Syndrome (IBS) Diagnostics Introduction
11.3.4 Gemelli Biotech Revenue in Irritable Bowel Syndrome (IBS) Diagnostics Business (2019-2024)
11.3.5 Gemelli Biotech Recent Development
11.4 Prometheus Laboratories
11.4.1 Prometheus Laboratories Company Detail
11.4.2 Prometheus Laboratories Business Overview
11.4.3 Prometheus Laboratories Irritable Bowel Syndrome (IBS) Diagnostics Introduction
11.4.4 Prometheus Laboratories Revenue in Irritable Bowel Syndrome (IBS) Diagnostics Business (2019-2024)
11.4.5 Prometheus Laboratories Recent Development
11.5 Inova Diagnostics, Inc.
11.5.1 Inova Diagnostics, Inc. Company Detail
11.5.2 Inova Diagnostics, Inc. Business Overview
11.5.3 Inova Diagnostics, Inc. Irritable Bowel Syndrome (IBS) Diagnostics Introduction
11.5.4 Inova Diagnostics, Inc. Revenue in Irritable Bowel Syndrome (IBS) Diagnostics Business (2019-2024)
11.5.5 Inova Diagnostics, Inc. Recent Development
11.6 Biohit Oyj
11.6.1 Biohit Oyj Company Detail
11.6.2 Biohit Oyj Business Overview
11.6.3 Biohit Oyj Irritable Bowel Syndrome (IBS) Diagnostics Introduction
11.6.4 Biohit Oyj Revenue in Irritable Bowel Syndrome (IBS) Diagnostics Business (2019-2024)
11.6.5 Biohit Oyj Recent Development
11.7 Aerodiagnostics, LLC.
11.7.1 Aerodiagnostics, LLC. Company Detail
11.7.2 Aerodiagnostics, LLC. Business Overview
11.7.3 Aerodiagnostics, LLC. Irritable Bowel Syndrome (IBS) Diagnostics Introduction
11.7.4 Aerodiagnostics, LLC. Revenue in Irritable Bowel Syndrome (IBS) Diagnostics Business (2019-2024)
11.7.5 Aerodiagnostics, LLC. Recent Development
11.8 Metabolic Solutions, Inc.
11.8.1 Metabolic Solutions, Inc. Company Detail
11.8.2 Metabolic Solutions, Inc. Business Overview
11.8.3 Metabolic Solutions, Inc. Irritable Bowel Syndrome (IBS) Diagnostics Introduction
11.8.4 Metabolic Solutions, Inc. Revenue in Irritable Bowel Syndrome (IBS) Diagnostics Business (2019-2024)
11.8.5 Metabolic Solutions, Inc. Recent Development
11.9 Sysmex Corporation
11.9.1 Sysmex Corporation Company Detail
11.9.2 Sysmex Corporation Business Overview
11.9.3 Sysmex Corporation Irritable Bowel Syndrome (IBS) Diagnostics Introduction
11.9.4 Sysmex Corporation Revenue in Irritable Bowel Syndrome (IBS) Diagnostics Business (2019-2024)
11.9.5 Sysmex Corporation Recent Development
11.10 Buhlmann Laboratories AG
11.10.1 Buhlmann Laboratories AG Company Detail
11.10.2 Buhlmann Laboratories AG Business Overview
11.10.3 Buhlmann Laboratories AG Irritable Bowel Syndrome (IBS) Diagnostics Introduction
11.10.4 Buhlmann Laboratories AG Revenue in Irritable Bowel Syndrome (IBS) Diagnostics Business (2019-2024)
11.10.5 Buhlmann Laboratories AG Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Irritable Bowel Syndrome (IBS) Diagnostics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Laboratory Tests
Table 3. Key Players of Imaging Tests
Table 4. Global Irritable Bowel Syndrome (IBS) Diagnostics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Irritable Bowel Syndrome (IBS) Diagnostics Market Share by Region (2019-2024)
Table 8. Global Irritable Bowel Syndrome (IBS) Diagnostics Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Irritable Bowel Syndrome (IBS) Diagnostics Market Share by Region (2025-2030)
Table 10. Irritable Bowel Syndrome (IBS) Diagnostics Market Trends
Table 11. Irritable Bowel Syndrome (IBS) Diagnostics Market Drivers
Table 12. Irritable Bowel Syndrome (IBS) Diagnostics Market Challenges
Table 13. Irritable Bowel Syndrome (IBS) Diagnostics Market Restraints
Table 14. Global Irritable Bowel Syndrome (IBS) Diagnostics Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Irritable Bowel Syndrome (IBS) Diagnostics Market Share by Players (2019-2024)
Table 16. Global Top Irritable Bowel Syndrome (IBS) Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Irritable Bowel Syndrome (IBS) Diagnostics as of 2023)
Table 17. Ranking of Global Top Irritable Bowel Syndrome (IBS) Diagnostics Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Irritable Bowel Syndrome (IBS) Diagnostics Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Irritable Bowel Syndrome (IBS) Diagnostics Product Solution and Service
Table 21. Date of Enter into Irritable Bowel Syndrome (IBS) Diagnostics Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Irritable Bowel Syndrome (IBS) Diagnostics Revenue Market Share by Type (2019-2024)
Table 25. Global Irritable Bowel Syndrome (IBS) Diagnostics Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Irritable Bowel Syndrome (IBS) Diagnostics Revenue Market Share by Type (2025-2030)
Table 27. Global Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Irritable Bowel Syndrome (IBS) Diagnostics Revenue Market Share by Application (2019-2024)
Table 29. Global Irritable Bowel Syndrome (IBS) Diagnostics Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Irritable Bowel Syndrome (IBS) Diagnostics Revenue Market Share by Application (2025-2030)
Table 31. North America Irritable Bowel Syndrome (IBS) Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Irritable Bowel Syndrome (IBS) Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Irritable Bowel Syndrome (IBS) Diagnostics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Irritable Bowel Syndrome (IBS) Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Irritable Bowel Syndrome (IBS) Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Country (2025-2030) & (US$ Million)
Table 46. Commonwealth Diagnostics International Company Detail
Table 47. Commonwealth Diagnostics International Business Overview
Table 48. Commonwealth Diagnostics International Irritable Bowel Syndrome (IBS) Diagnostics Product
Table 49. Commonwealth Diagnostics International Revenue in Irritable Bowel Syndrome (IBS) Diagnostics Business (2019-2024) & (US$ Million)
Table 50. Commonwealth Diagnostics International Recent Development
Table 51. Genova Diagnostics Company Detail
Table 52. Genova Diagnostics Business Overview
Table 53. Genova Diagnostics Irritable Bowel Syndrome (IBS) Diagnostics Product
Table 54. Genova Diagnostics Revenue in Irritable Bowel Syndrome (IBS) Diagnostics Business (2019-2024) & (US$ Million)
Table 55. Genova Diagnostics Recent Development
Table 56. Gemelli Biotech Company Detail
Table 57. Gemelli Biotech Business Overview
Table 58. Gemelli Biotech Irritable Bowel Syndrome (IBS) Diagnostics Product
Table 59. Gemelli Biotech Revenue in Irritable Bowel Syndrome (IBS) Diagnostics Business (2019-2024) & (US$ Million)
Table 60. Gemelli Biotech Recent Development
Table 61. Prometheus Laboratories Company Detail
Table 62. Prometheus Laboratories Business Overview
Table 63. Prometheus Laboratories Irritable Bowel Syndrome (IBS) Diagnostics Product
Table 64. Prometheus Laboratories Revenue in Irritable Bowel Syndrome (IBS) Diagnostics Business (2019-2024) & (US$ Million)
Table 65. Prometheus Laboratories Recent Development
Table 66. Inova Diagnostics, Inc. Company Detail
Table 67. Inova Diagnostics, Inc. Business Overview
Table 68. Inova Diagnostics, Inc. Irritable Bowel Syndrome (IBS) Diagnostics Product
Table 69. Inova Diagnostics, Inc. Revenue in Irritable Bowel Syndrome (IBS) Diagnostics Business (2019-2024) & (US$ Million)
Table 70. Inova Diagnostics, Inc. Recent Development
Table 71. Biohit Oyj Company Detail
Table 72. Biohit Oyj Business Overview
Table 73. Biohit Oyj Irritable Bowel Syndrome (IBS) Diagnostics Product
Table 74. Biohit Oyj Revenue in Irritable Bowel Syndrome (IBS) Diagnostics Business (2019-2024) & (US$ Million)
Table 75. Biohit Oyj Recent Development
Table 76. Aerodiagnostics, LLC. Company Detail
Table 77. Aerodiagnostics, LLC. Business Overview
Table 78. Aerodiagnostics, LLC. Irritable Bowel Syndrome (IBS) Diagnostics Product
Table 79. Aerodiagnostics, LLC. Revenue in Irritable Bowel Syndrome (IBS) Diagnostics Business (2019-2024) & (US$ Million)
Table 80. Aerodiagnostics, LLC. Recent Development
Table 81. Metabolic Solutions, Inc. Company Detail
Table 82. Metabolic Solutions, Inc. Business Overview
Table 83. Metabolic Solutions, Inc. Irritable Bowel Syndrome (IBS) Diagnostics Product
Table 84. Metabolic Solutions, Inc. Revenue in Irritable Bowel Syndrome (IBS) Diagnostics Business (2019-2024) & (US$ Million)
Table 85. Metabolic Solutions, Inc. Recent Development
Table 86. Sysmex Corporation Company Detail
Table 87. Sysmex Corporation Business Overview
Table 88. Sysmex Corporation Irritable Bowel Syndrome (IBS) Diagnostics Product
Table 89. Sysmex Corporation Revenue in Irritable Bowel Syndrome (IBS) Diagnostics Business (2019-2024) & (US$ Million)
Table 90. Sysmex Corporation Recent Development
Table 91. Buhlmann Laboratories AG Company Detail
Table 92. Buhlmann Laboratories AG Business Overview
Table 93. Buhlmann Laboratories AG Irritable Bowel Syndrome (IBS) Diagnostics Product
Table 94. Buhlmann Laboratories AG Revenue in Irritable Bowel Syndrome (IBS) Diagnostics Business (2019-2024) & (US$ Million)
Table 95. Buhlmann Laboratories AG Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Irritable Bowel Syndrome (IBS) Diagnostics Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Irritable Bowel Syndrome (IBS) Diagnostics Market Share by Type: 2023 VS 2030
Figure 3. Laboratory Tests Features
Figure 4. Imaging Tests Features
Figure 5. Global Irritable Bowel Syndrome (IBS) Diagnostics Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Irritable Bowel Syndrome (IBS) Diagnostics Market Share by Application: 2023 VS 2030
Figure 7. Hospitals and Clinics Case Studies
Figure 8. Diagnostic Centers Case Studies
Figure 9. Others Case Studies
Figure 10. Irritable Bowel Syndrome (IBS) Diagnostics Report Years Considered
Figure 11. Global Irritable Bowel Syndrome (IBS) Diagnostics Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Irritable Bowel Syndrome (IBS) Diagnostics Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Irritable Bowel Syndrome (IBS) Diagnostics Market Share by Region: 2023 VS 2030
Figure 14. Global Irritable Bowel Syndrome (IBS) Diagnostics Market Share by Players in 2023
Figure 15. Global Top Irritable Bowel Syndrome (IBS) Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Irritable Bowel Syndrome (IBS) Diagnostics as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Irritable Bowel Syndrome (IBS) Diagnostics Revenue in 2023
Figure 17. North America Irritable Bowel Syndrome (IBS) Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Irritable Bowel Syndrome (IBS) Diagnostics Market Share by Country (2019-2030)
Figure 19. United States Irritable Bowel Syndrome (IBS) Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada Irritable Bowel Syndrome (IBS) Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Irritable Bowel Syndrome (IBS) Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Irritable Bowel Syndrome (IBS) Diagnostics Market Share by Country (2019-2030)
Figure 23. Germany Irritable Bowel Syndrome (IBS) Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France Irritable Bowel Syndrome (IBS) Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. Irritable Bowel Syndrome (IBS) Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy Irritable Bowel Syndrome (IBS) Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia Irritable Bowel Syndrome (IBS) Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries Irritable Bowel Syndrome (IBS) Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Irritable Bowel Syndrome (IBS) Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Irritable Bowel Syndrome (IBS) Diagnostics Market Share by Region (2019-2030)
Figure 31. China Irritable Bowel Syndrome (IBS) Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan Irritable Bowel Syndrome (IBS) Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea Irritable Bowel Syndrome (IBS) Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia Irritable Bowel Syndrome (IBS) Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India Irritable Bowel Syndrome (IBS) Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia Irritable Bowel Syndrome (IBS) Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Irritable Bowel Syndrome (IBS) Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Irritable Bowel Syndrome (IBS) Diagnostics Market Share by Country (2019-2030)
Figure 39. Mexico Irritable Bowel Syndrome (IBS) Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil Irritable Bowel Syndrome (IBS) Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Irritable Bowel Syndrome (IBS) Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Irritable Bowel Syndrome (IBS) Diagnostics Market Share by Country (2019-2030)
Figure 43. Turkey Irritable Bowel Syndrome (IBS) Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia Irritable Bowel Syndrome (IBS) Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Commonwealth Diagnostics International Revenue Growth Rate in Irritable Bowel Syndrome (IBS) Diagnostics Business (2019-2024)
Figure 46. Genova Diagnostics Revenue Growth Rate in Irritable Bowel Syndrome (IBS) Diagnostics Business (2019-2024)
Figure 47. Gemelli Biotech Revenue Growth Rate in Irritable Bowel Syndrome (IBS) Diagnostics Business (2019-2024)
Figure 48. Prometheus Laboratories Revenue Growth Rate in Irritable Bowel Syndrome (IBS) Diagnostics Business (2019-2024)
Figure 49. Inova Diagnostics, Inc. Revenue Growth Rate in Irritable Bowel Syndrome (IBS) Diagnostics Business (2019-2024)
Figure 50. Biohit Oyj Revenue Growth Rate in Irritable Bowel Syndrome (IBS) Diagnostics Business (2019-2024)
Figure 51. Aerodiagnostics, LLC. Revenue Growth Rate in Irritable Bowel Syndrome (IBS) Diagnostics Business (2019-2024)
Figure 52. Metabolic Solutions, Inc. Revenue Growth Rate in Irritable Bowel Syndrome (IBS) Diagnostics Business (2019-2024)
Figure 53. Sysmex Corporation Revenue Growth Rate in Irritable Bowel Syndrome (IBS) Diagnostics Business (2019-2024)
Figure 54. Buhlmann Laboratories AG Revenue Growth Rate in Irritable Bowel Syndrome (IBS) Diagnostics Business (2019-2024)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
Table 1. Global Irritable Bowel Syndrome (IBS) Diagnostics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Laboratory Tests
Table 3. Key Players of Imaging Tests
Table 4. Global Irritable Bowel Syndrome (IBS) Diagnostics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Irritable Bowel Syndrome (IBS) Diagnostics Market Share by Region (2019-2024)
Table 8. Global Irritable Bowel Syndrome (IBS) Diagnostics Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Irritable Bowel Syndrome (IBS) Diagnostics Market Share by Region (2025-2030)
Table 10. Irritable Bowel Syndrome (IBS) Diagnostics Market Trends
Table 11. Irritable Bowel Syndrome (IBS) Diagnostics Market Drivers
Table 12. Irritable Bowel Syndrome (IBS) Diagnostics Market Challenges
Table 13. Irritable Bowel Syndrome (IBS) Diagnostics Market Restraints
Table 14. Global Irritable Bowel Syndrome (IBS) Diagnostics Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Irritable Bowel Syndrome (IBS) Diagnostics Market Share by Players (2019-2024)
Table 16. Global Top Irritable Bowel Syndrome (IBS) Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Irritable Bowel Syndrome (IBS) Diagnostics as of 2023)
Table 17. Ranking of Global Top Irritable Bowel Syndrome (IBS) Diagnostics Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Irritable Bowel Syndrome (IBS) Diagnostics Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Irritable Bowel Syndrome (IBS) Diagnostics Product Solution and Service
Table 21. Date of Enter into Irritable Bowel Syndrome (IBS) Diagnostics Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Irritable Bowel Syndrome (IBS) Diagnostics Revenue Market Share by Type (2019-2024)
Table 25. Global Irritable Bowel Syndrome (IBS) Diagnostics Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Irritable Bowel Syndrome (IBS) Diagnostics Revenue Market Share by Type (2025-2030)
Table 27. Global Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Irritable Bowel Syndrome (IBS) Diagnostics Revenue Market Share by Application (2019-2024)
Table 29. Global Irritable Bowel Syndrome (IBS) Diagnostics Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Irritable Bowel Syndrome (IBS) Diagnostics Revenue Market Share by Application (2025-2030)
Table 31. North America Irritable Bowel Syndrome (IBS) Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Irritable Bowel Syndrome (IBS) Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Irritable Bowel Syndrome (IBS) Diagnostics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Irritable Bowel Syndrome (IBS) Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Irritable Bowel Syndrome (IBS) Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Country (2025-2030) & (US$ Million)
Table 46. Commonwealth Diagnostics International Company Detail
Table 47. Commonwealth Diagnostics International Business Overview
Table 48. Commonwealth Diagnostics International Irritable Bowel Syndrome (IBS) Diagnostics Product
Table 49. Commonwealth Diagnostics International Revenue in Irritable Bowel Syndrome (IBS) Diagnostics Business (2019-2024) & (US$ Million)
Table 50. Commonwealth Diagnostics International Recent Development
Table 51. Genova Diagnostics Company Detail
Table 52. Genova Diagnostics Business Overview
Table 53. Genova Diagnostics Irritable Bowel Syndrome (IBS) Diagnostics Product
Table 54. Genova Diagnostics Revenue in Irritable Bowel Syndrome (IBS) Diagnostics Business (2019-2024) & (US$ Million)
Table 55. Genova Diagnostics Recent Development
Table 56. Gemelli Biotech Company Detail
Table 57. Gemelli Biotech Business Overview
Table 58. Gemelli Biotech Irritable Bowel Syndrome (IBS) Diagnostics Product
Table 59. Gemelli Biotech Revenue in Irritable Bowel Syndrome (IBS) Diagnostics Business (2019-2024) & (US$ Million)
Table 60. Gemelli Biotech Recent Development
Table 61. Prometheus Laboratories Company Detail
Table 62. Prometheus Laboratories Business Overview
Table 63. Prometheus Laboratories Irritable Bowel Syndrome (IBS) Diagnostics Product
Table 64. Prometheus Laboratories Revenue in Irritable Bowel Syndrome (IBS) Diagnostics Business (2019-2024) & (US$ Million)
Table 65. Prometheus Laboratories Recent Development
Table 66. Inova Diagnostics, Inc. Company Detail
Table 67. Inova Diagnostics, Inc. Business Overview
Table 68. Inova Diagnostics, Inc. Irritable Bowel Syndrome (IBS) Diagnostics Product
Table 69. Inova Diagnostics, Inc. Revenue in Irritable Bowel Syndrome (IBS) Diagnostics Business (2019-2024) & (US$ Million)
Table 70. Inova Diagnostics, Inc. Recent Development
Table 71. Biohit Oyj Company Detail
Table 72. Biohit Oyj Business Overview
Table 73. Biohit Oyj Irritable Bowel Syndrome (IBS) Diagnostics Product
Table 74. Biohit Oyj Revenue in Irritable Bowel Syndrome (IBS) Diagnostics Business (2019-2024) & (US$ Million)
Table 75. Biohit Oyj Recent Development
Table 76. Aerodiagnostics, LLC. Company Detail
Table 77. Aerodiagnostics, LLC. Business Overview
Table 78. Aerodiagnostics, LLC. Irritable Bowel Syndrome (IBS) Diagnostics Product
Table 79. Aerodiagnostics, LLC. Revenue in Irritable Bowel Syndrome (IBS) Diagnostics Business (2019-2024) & (US$ Million)
Table 80. Aerodiagnostics, LLC. Recent Development
Table 81. Metabolic Solutions, Inc. Company Detail
Table 82. Metabolic Solutions, Inc. Business Overview
Table 83. Metabolic Solutions, Inc. Irritable Bowel Syndrome (IBS) Diagnostics Product
Table 84. Metabolic Solutions, Inc. Revenue in Irritable Bowel Syndrome (IBS) Diagnostics Business (2019-2024) & (US$ Million)
Table 85. Metabolic Solutions, Inc. Recent Development
Table 86. Sysmex Corporation Company Detail
Table 87. Sysmex Corporation Business Overview
Table 88. Sysmex Corporation Irritable Bowel Syndrome (IBS) Diagnostics Product
Table 89. Sysmex Corporation Revenue in Irritable Bowel Syndrome (IBS) Diagnostics Business (2019-2024) & (US$ Million)
Table 90. Sysmex Corporation Recent Development
Table 91. Buhlmann Laboratories AG Company Detail
Table 92. Buhlmann Laboratories AG Business Overview
Table 93. Buhlmann Laboratories AG Irritable Bowel Syndrome (IBS) Diagnostics Product
Table 94. Buhlmann Laboratories AG Revenue in Irritable Bowel Syndrome (IBS) Diagnostics Business (2019-2024) & (US$ Million)
Table 95. Buhlmann Laboratories AG Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Irritable Bowel Syndrome (IBS) Diagnostics Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Irritable Bowel Syndrome (IBS) Diagnostics Market Share by Type: 2023 VS 2030
Figure 3. Laboratory Tests Features
Figure 4. Imaging Tests Features
Figure 5. Global Irritable Bowel Syndrome (IBS) Diagnostics Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Irritable Bowel Syndrome (IBS) Diagnostics Market Share by Application: 2023 VS 2030
Figure 7. Hospitals and Clinics Case Studies
Figure 8. Diagnostic Centers Case Studies
Figure 9. Others Case Studies
Figure 10. Irritable Bowel Syndrome (IBS) Diagnostics Report Years Considered
Figure 11. Global Irritable Bowel Syndrome (IBS) Diagnostics Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Irritable Bowel Syndrome (IBS) Diagnostics Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Irritable Bowel Syndrome (IBS) Diagnostics Market Share by Region: 2023 VS 2030
Figure 14. Global Irritable Bowel Syndrome (IBS) Diagnostics Market Share by Players in 2023
Figure 15. Global Top Irritable Bowel Syndrome (IBS) Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Irritable Bowel Syndrome (IBS) Diagnostics as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Irritable Bowel Syndrome (IBS) Diagnostics Revenue in 2023
Figure 17. North America Irritable Bowel Syndrome (IBS) Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Irritable Bowel Syndrome (IBS) Diagnostics Market Share by Country (2019-2030)
Figure 19. United States Irritable Bowel Syndrome (IBS) Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada Irritable Bowel Syndrome (IBS) Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Irritable Bowel Syndrome (IBS) Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Irritable Bowel Syndrome (IBS) Diagnostics Market Share by Country (2019-2030)
Figure 23. Germany Irritable Bowel Syndrome (IBS) Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France Irritable Bowel Syndrome (IBS) Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. Irritable Bowel Syndrome (IBS) Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy Irritable Bowel Syndrome (IBS) Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia Irritable Bowel Syndrome (IBS) Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries Irritable Bowel Syndrome (IBS) Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Irritable Bowel Syndrome (IBS) Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Irritable Bowel Syndrome (IBS) Diagnostics Market Share by Region (2019-2030)
Figure 31. China Irritable Bowel Syndrome (IBS) Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan Irritable Bowel Syndrome (IBS) Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea Irritable Bowel Syndrome (IBS) Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia Irritable Bowel Syndrome (IBS) Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India Irritable Bowel Syndrome (IBS) Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia Irritable Bowel Syndrome (IBS) Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Irritable Bowel Syndrome (IBS) Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Irritable Bowel Syndrome (IBS) Diagnostics Market Share by Country (2019-2030)
Figure 39. Mexico Irritable Bowel Syndrome (IBS) Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil Irritable Bowel Syndrome (IBS) Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Irritable Bowel Syndrome (IBS) Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Irritable Bowel Syndrome (IBS) Diagnostics Market Share by Country (2019-2030)
Figure 43. Turkey Irritable Bowel Syndrome (IBS) Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia Irritable Bowel Syndrome (IBS) Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Commonwealth Diagnostics International Revenue Growth Rate in Irritable Bowel Syndrome (IBS) Diagnostics Business (2019-2024)
Figure 46. Genova Diagnostics Revenue Growth Rate in Irritable Bowel Syndrome (IBS) Diagnostics Business (2019-2024)
Figure 47. Gemelli Biotech Revenue Growth Rate in Irritable Bowel Syndrome (IBS) Diagnostics Business (2019-2024)
Figure 48. Prometheus Laboratories Revenue Growth Rate in Irritable Bowel Syndrome (IBS) Diagnostics Business (2019-2024)
Figure 49. Inova Diagnostics, Inc. Revenue Growth Rate in Irritable Bowel Syndrome (IBS) Diagnostics Business (2019-2024)
Figure 50. Biohit Oyj Revenue Growth Rate in Irritable Bowel Syndrome (IBS) Diagnostics Business (2019-2024)
Figure 51. Aerodiagnostics, LLC. Revenue Growth Rate in Irritable Bowel Syndrome (IBS) Diagnostics Business (2019-2024)
Figure 52. Metabolic Solutions, Inc. Revenue Growth Rate in Irritable Bowel Syndrome (IBS) Diagnostics Business (2019-2024)
Figure 53. Sysmex Corporation Revenue Growth Rate in Irritable Bowel Syndrome (IBS) Diagnostics Business (2019-2024)
Figure 54. Buhlmann Laboratories AG Revenue Growth Rate in Irritable Bowel Syndrome (IBS) Diagnostics Business (2019-2024)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Smart Potentiometric Titrator - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nov 05, 24
Multifunctional Zeta Potential Analyzer - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nov 05, 24
Ultrapure Water pH Sensor - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nov 05, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232